Intraoperative neuromonitoring market by products & services (systems, accessories, and services) source type (insourced monitoring and outsourced monitoring), application (spinal surgery, neurosurgery, vascular surgery, ENT surgery, and orthopaedic surgery), modality (motor evoked potentials (MEPs), somatosensory evoked potentials (SSEPS), electroencephalography (EEG), electromyography (EMG), brainstem auditory evoked potentials (BAEPS), and visual evoked potentials (VEPS)) and end user (hospitals and ambulatory surgical centers (ASCS))
Intraoperative neurophysiologic monitoring (IONM) or intraoperative neuromonitoring is a technique to reduce the risk of neurological deficits after operations that involve the nervous system. IONM has evolved in the last two decades; it utilizes recordings of electrical potentials from the nervous system during surgical procedures. The use of neuromonitoring offers an opportunity to detect injuries before they become so severe that they cause deficits after the operation. Therefore, with the introduction of IONM, the risk of debilitating deficits such as muscle weakness, paralysis, hearing loss, and other loss of normal body functions are reduced.
Ageing population, increase in the number of surgical procedures, increased awareness regarding benefits of IONM in developed regions, and risk management through IONM during complex surgeries drive the market. However, low awareness of IONM in developing nations and dearth of skilled professionals hamper the growth. Conversely, applications of IONM in different surgeries and growth opportunities in the emerging economies of the Asia-pacific and LAMEA regions are expected to provide several opportunities for market growth during the forecast period.
The report segments the market based on products & services, source type, application, modality, end user, and region. Based on products & services, the market is segmented into systems, accessories and services. Based on source type, the market is bifurcated into insourced and outsourced monitoring. The end-user segment is categorized into hospitals and ambulatory surgical centers (ASCS). IONM finds its application in spinal surgery, neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, and other surgeries related to the central or peripheral nervous system. IONM modalities include motor evoked potentials (MEPs), somatosensory evoked potentials (SSEPS), electroencephalography (EEG), electromyography (EMG), brainstem auditory evoked potentials (BAEPS) and visual evoked potentials (veps). Based on region, the market is analyzed across North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, UK, Spain, and rest of Europe), Asia-pacific (China, Japan, Australia, India, South Korea and Rest of Asia-pacific), and LAMEA (brazil, South Africa, Saudi Arabia and rest of LAMEA).
Key players operating in the global intraoperative neuromonitoring market include Medtronic Plc, Nuvasive, Inc., Computational Diagnostics, Inc., Specialtycare, Natus Medical Incorporated., Intranerve, Llc, Inomed Medizintechnik Gmbh, Accuratemonitoring Llc, Nihon Kohden Corporation, and Day One Medical, Llc.
Key benefits for stakeholders
The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
The report provides a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis by application helps understand the various types of surgeries that may require IONM.
Competitive intelligence highlights the business practices followed by leading players across various regions.
Comprehensive analysis of all geographical regions is provided, which determines the prevailing opportunities in these geographies.
Key players are profiled in the report and their strategies are analyzed thoroughly, which helps understand competitive outlook of the global market.
Intraoperative neuromonitoring market key segments
By Products & Services
By Source Type
Motor Evoked Potentials (Meps)
Somatosensory Evoked Potentials (Sseps)
Brainstem Auditory Evoked Potentials (Baeps)
Visual Evoked Potentials (Veps)
By End User
Ambulatory Surgical Centers (ASCS)
Rest Of Europe
Rest Of Asia-Pacific
Rest of LAMEA
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
Chapter 2 Executive Summary
2.1. Key Findings Of The Study
2.2. CXO Perspective
Chapter 3 Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
188.8.131.52. Competitive Intelligence Of Companies And Their Strategies
3.3. Player Positioning, 2015
3.4. Market Dynamics
184.108.40.206. Growing Geriatric Population
220.127.116.11. Increasing Prevalence Of Chronic Disorders
18.104.22.168. Applications Of Ionm In Different Surgeries
22.214.171.124. Risk Management Through Ionm During Complex Surgeries
126.96.36.199. Low Awareness Of Ionm In Developing Nations
188.8.131.52. Dearth Of Skilled Professionals
184.108.40.206. Increasing Medical Tourism
220.127.116.11. Growth Opportunities In The Emerging Economies
3.4.4. Impact Analysis
3.5. Clinical Trials
3.6. Reimbursement Scenario In U.S.
Chapter 4 Intraoperative Neuromonitoring Market By Products & Services
4.1.1. Market Size And Forecast
4.2.1. Market Size And Forecast
4.3.1. Market Size And Forecast
4.4.1. Market Size And Forecast
Chapter 5 Intraoperative Neuromonitoring Market, By Source Type
5.1.1. Market Size And Forecast
5.2. Insourced Monitoring
5.2.1. Key Market Trends
5.2.2. Key Growth Factors And Opportunities
5.2.3. Market Size And Forecast
5.3. Outsourced Monitoring
5.3.1. Key Market Trends
5.3.2. Key Growth Factors And Opportunities
5.3.3. Market Size And Forecast
Chapter 6 Intraoperative Neuromonitoring Market, By Modality
6.1.1. Market Size And Forecast
6.2. Somatosensory Evoked Potentials (Sseps)
6.2.1. Market Size And Forecast
6.3. Electromyography (Emg)
6.3.1. Market Size And Forecast
6.4. Electroencephalography (Eeg)
6.4.1. Market Size And Forecast
6.5. Brainstem Auditory Evoked Potentials (Baeps)
6.5.1. Market Size And Forecast
6.6. Motor Evoked Potentials (Meps)
6.6.1. Market Size And Forecast
6.7. Visual Evoked Potentials (Veps)
6.7.1. Market Size And Forecast
Chapter 7 Intraoperative Neuromonitoring Market, By Application
7.1.1. Market Size And Forecast
7.2. Spinal Surgery
7.2.1. Market Size And Forecast
7.3. Ent Surgery
7.3.1. Market Size And Forecast
7.4.1. Market Size And Forecast
7.5. Vascular Surgery
7.5.1. Market Size And Forecast
7.6. Orthopedic Surgery
7.6.1. Market Size And Forecast
7.7. Other Surgeries
7.7.1. Market Size And Forecast
Chapter 8 Intraoperative Neuromonitoring Market, By End User
8.1.1. Market Size And Forecast
8.2.1. Market Size And Forecast
8.3. Ambulatory Surgical Centers (Ascs)
8.3.1. Market Size And Forecast
Chapter 9 Intraoperative Neuromonitoring Market, By Region
9.1.1. Market Size And Forecast
9.2. North America
9.2.1. Key Market Trends
9.2.2. Key Growth Factors And Opportunities
9.2.3. Market Size And Forecast
9.3.1. Key Market Trends
9.3.2. Key Growth Factors And Opportunities
9.3.3. Market Size And Forecast
9.3.9. Rest Of Europe
9.4.1. Key Market Trends
9.4.2. Key Growth Factors And Opportunities
9.4.3. Market Size And Forecast
9.4.7. South Korea
9.4.9. Rest Of Asia-Pacific
9.5.1. Key Market Trends
9.5.2. Key Growth Factors And Opportunities
9.5.3. Market Size And Forecast
9.5.5. South Africa
9.5.6. Saudi Arabia
9.5.7. Rest Of Lamea
Chapter 10 Company Profiles
10.1. Accurate Monitoring, Llc
10.1.1. Company Overview
10.1.2. Company Snapshot
10.1.3. Key Strategic Moves & Developments
10.2. Computational Diagnostics, Inc.
10.2.1. Company Overview
10.2.2. Company Snapshot
10.2.3. Key Strategic Moves & Developments
10.3. Inomed Medizintechnik Gmbh
10.3.1. Company Overview
10.3.2. Company Snapshot
10.3.3. Operating Business Segments
10.3.4. Key Strategic Moves & Developments
10.4. Intranerve, Llc
10.4.1. Company Overview
10.4.2. Company Snapshot
10.4.3. Key Strategic Moves & Developments
10.5. Medtronic Plc
10.5.1. Company Overview
10.5.2. Company Snapshot
10.5.3. Operating Business Segments
10.5.4. Business Performance
10.5.5. Key Strategic Moves & Developments
10.6. Moberg Research, Inc
10.6.1. Company Overview
10.6.2. Company Snapshot
10.6.3. Operating Business Segments
10.6.4. Key Strategic Moves & Developments
10.7. Natus Medical Incorporated.
10.7.1. Company Overview
10.7.2. Company Snapshot
10.7.3. Operating Business Segments
10.7.4. Business Performance
10.7.5. Key Strategic Moves & Developments
10.8. Nihon Kohden Corporation
10.8.1. Company Overview
10.8.2. Company Snapshot
10.8.3. Operating Business Segments
10.8.4. Business Performance
10.8.5. Key Strategic Moves & Developments
10.9. Nuvasive, Inc.
10.9.1. Company Overview
10.9.2. Company Snapshot
10.9.3. Operating Business Segments
10.9.4. Business Performance
10.9.5. Key Strategic Moves & Developments
10.10.1. Company Overview
10.10.2. Company Snapshot
10.10.4. Key Strategic Moves & Developments
IONM systems segment accounted for nearly half of the total market in 2015. IONM systems help in the identification of neural structures during a surgery. This helps the surgeons to prevent any damage to the nervous system, which may be caused during the surgery and reduce post-operative complications. Thus, IONM systems identify any progressive threat to the nervous system and alert the surgeon prior to reaching the patients threshold for injury.
Ageing population, increase in prevalence of chronic disorders, applications of IONM in different surgeries, and risk management through IONM during complex surgeries drive the market. However, low awareness of IONM in developing nations and lack of skilled professionals restrain the market growth. Increase in medical tourism and growth opportunities in the emerging economies of the Asia-Pacific and LAMEA regions are expected to provide several opportunities for key players.
Outsourced IONM monitoring is growing at a fast pace due to its benefits over insourced monitoring. Now-a-days, hospitals do not prefer insourced monitoring as they have to appoint a full-time employee with the required skill set and they cannot offer the training standardization required to improve the quality of service. Thus, outsourced monitoring is in demand among hospitals and ASCs, and the market gradually shifts toward outsourced monitoring services.
IONM is most commonly used during spinal and neurosurgery. However, there is an increase in the use of IONM for orthopedic as well as ENT surgeries as these surgeries pose a potential risk to the neural structures and require a technique, which protects nerves (and other related structures) during the procedure.
Key findings of the Intraoperative Neuromonitoring Market
Based on applications, spinal surgery segment accounted for one-third of the total market in 2015. However, orthopedic surgery is the fastest growing application of IONM (which is expected to grow with a CAGR of 7.4% from 2016 to 2022)
Electromyography (EMG) modality accounted for more than one-fourth of the global market in 2015.
IONM services segment is expected to grow at a high CAGR of 10.0% during the forecast period, due to an increase in the demand for IONM service providers.
Hospitals accounted for nearly three-fifths of the total market in 2015.
Asia-Pacific is expected grow at a high CAGR of 8.2%, owing to the presence of ample growth opportunities in terms of unmet medical needs for IONM services in the region.
North America accounted for majority of the share (more than two-fifths) in the market in 2015, and is expected to remain dominant throughout the forecast period. This is attributed to the presence of a large number of hospitals, and increase in number of surgeries in the region. In addition, awareness among people for IONM is anticipated to provide new growth opportunities for the key players in this market. In addition, rise in geriatric population, increase in incidence of spinal deformities, spinal stenosis, disc compression, and other chronic disorders drive the IONM market in Europe.
The major companies profiled in the report include Medtronic plc, NuVasive, Inc., Computational Diagnostics, Inc., SpecialtyCare, Natus Medical Incorporated., IntraNerve, LLC, inomed Medizintechnik GmbH, AccurateMonitoring LLC, Nihon Kohden Corporation, and Moberg Research, Inc.